Gland Pharma Ltd. Share Price Today
Techno Funda Ratings
Key Metrics
Current Price
₹2379.8Market Cap
₹ 39,257 Cr.Stock P/E
37.6ROE
10.7 %RSI
42.14Trend
BullishShare Price Chart
Technical Commentary
Buy or Sell Analysis
Company Overview
Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. We operate primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing and marketing of complex injectables. This presence across the value chain has helped us witness exponential growth. We are promoted by Shanghai Fosun Pharma, a global pharmaceutical major.
Gland Pharma Ltd share price remains one of the actively tracked stocks on NSE among traders and long term investors.
The latest Gland Pharma Ltd share price NSE movement reflects ongoing investor interest driven by company fundamentals, sector performance and broader market sentiment.
From a technical analysis perspective, the Gland Pharma Ltd share price chart currently indicates a Bullish trend based on moving averages and RSI momentum analysis.
Technical Analysis
| Indicator | Value |
|---|---|
| Current Price | 2379.8 |
| RSI (14) | 42.14 |
| 50 DMA | 2342.82 |
| 200 DMA | 1920.11 |
| Trend | Bullish |
| A/D Rating | A |
| RS Rating | 50 |
| EPS Rating | 50 |
| TI65 | 1.1 |
| TI65 Trend | Bullish |
Pivot Points Analysis
Daily pivot points for Gland Pharma Ltd. calculated using previous trading session data. These levels help traders identify intraday support, resistance and breakout zones using Classic Pivot Point methodology.
Classic Pivot Points
| Level | Value |
|---|---|
| R3 | ₹2456.6 |
| R2 | ₹2435.8 |
| R1 | ₹2407.8 |
| PP | ₹2387 |
| S1 | ₹2359 |
| S2 | ₹2338.2 |
| S3 | ₹2310.2 |
Financial Ratios
| Metric | Value |
|---|---|
| Market Cap | ₹ 39,257 Cr. |
| Current Price | ₹ 2,380 |
| High / Low | ₹ 2,574 / 1,574 |
| Stock P/E | 37.6 |
| Book Value | ₹ 629 |
| Dividend Yield | 0.84 % |
| ROCE | 15.1 % |
| ROE | 10.7 % |
| Face Value | ₹ 1.00 |
Quarterly Results
| Quarter | Sales | Profit | OPM |
|---|---|---|---|
| Mar 2023 | 785 | 79 | 21% |
| Jun 2023 | 1,209 | 194 | 24% |
| Sep 2023 | 1,373 | 194 | 24% |
| Dec 2023 | 1,545 | 192 | 23% |
| Mar 2024 | 1,537 | 192 | 23% |
| Jun 2024 | 1,402 | 144 | 19% |
| Sep 2024 | 1,406 | 164 | 21% |
| Dec 2024 | 1,384 | 205 | 26% |
| Mar 2025 | 1,425 | 187 | 24% |
| Jun 2025 | 1,506 | 215 | 24% |
| Sep 2025 | 1,487 | 184 | 21% |
| Dec 2025 | 1,695 | 261 | 26% |
| Mar 2026 | 1,743 | 367 | 29% |
Shareholding Pattern
| Holder | Holding |
|---|---|
| Promoters | 58.25% |
| FIIs | 11.87% |
| DIIs | 11.25% |
| Public | 18.63% |
| No. of Shareholders | 84,467 |
Pros and Cons
Pros
- Strong technical momentum with price holding comfortably above the 50 DMA (2342.82).
Cons
Related NSE Stocks
Leela Palaces Hotels & Resorts Ltd.
View Share Price Analysis →Hero MotoCorp Ltd.
View Share Price Analysis →ZF Commercial Vehicle Control Systems India Ltd.
View Share Price Analysis →Kalpataru Projects International Ltd.
View Share Price Analysis →Dr. Lal Path Labs Ltd.
View Share Price Analysis →Afcons Infrastructure Ltd.
View Share Price Analysis →UPL Ltd.
View Share Price Analysis →Aditya Birla Lifestyle Brands Ltd.
View Share Price Analysis →Nestle India Ltd.
View Share Price Analysis →Nuvama Wealth Management Ltd.
View Share Price Analysis →Persistent Systems Ltd.
View Share Price Analysis →K.P.R. Mill Ltd.
View Share Price Analysis →Frequently Asked Questions
What is the current technical trend and RSI for Gland Pharma Ltd share?
Based on the latest closing data, the technical momentum for Gland Pharma Ltd is currently evaluated as Bullish. The stock is exhibiting an RSI (14) of 42.14, indicating it is trading in a neutral balanced zone. Key tracking supports are currently located near the daily pivots, with price relative to the 50 DMA (2342.82) defining immediate multi-day trend patterns.
What are the key resistance and support pivot points for Gland Pharma Ltd?
According to Classic Pivot Point methodologies, the core trading floor for Gland Pharma Ltd today centers at a Pivot Point (PP) of ₹2387. Upside resistance challenges are calculated at R1: ₹2407.8, R2: ₹2435.8, and R3: ₹2456.6. Conversely, if selling pressure intensifies, immediate floor support targets are positioned at S1: ₹2359, S2: ₹2338.2, and S3: ₹2310.2.
How does the fundamental ROE and P/E ratio look for Gland Pharma Ltd?
Gland Pharma Ltd is currently trading with a valuation metrics context of a Stock P/E of 37.6, against a core structural efficiency Return on Equity (ROE) standing at 10.7 %. This fundamental operational efficiency baseline is coupled with an EPS Rating of 50, allowing investors to track how corporate profitability trends align with current price discovery cycles on the National Stock Exchange (NSE).
Should I buy or sell Gland Pharma Ltd shares based on corporate rankings?
Our dynamic trade matrix suggests a status of: Speculative Momentum Phase (Neutral / Hold). Gland Pharma Ltd is trading above i... For long-term portfolios, decision-making should match the stock's market performance profile, which currently displays an institutional Accumulation/Distribution (A/D) grade of A, a Relative Strength (RS) ranking of 50, and long-term trend backing from the TI65 indicator (Bullish pattern).